AUD 0.01
(-16.67%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 5.57 Million AUD | -27.93% |
2023 | 7.73 Million AUD | -27.38% |
2022 | 10.64 Million AUD | 17.67% |
2021 | 9.04 Million AUD | 31.01% |
2020 | 6.9 Million AUD | -25.81% |
2019 | 9.31 Million AUD | 109.73% |
2018 | 4.43 Million AUD | -45.13% |
2017 | 8.08 Million AUD | -24.6% |
2016 | 10.72 Million AUD | 1009.52% |
2015 | 967.07 Thousand AUD | 110.34% |
2014 | 459.76 Thousand AUD | -24.35% |
2013 | 607.75 Thousand AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 FY | 5.57 Million AUD | -27.93% |
2024 Q2 | 5.29 Million AUD | 0.0% |
2024 Q4 | 5.57 Million AUD | 0.0% |
2023 Q2 | 7.67 Million AUD | 0.0% |
2023 FY | 7.73 Million AUD | -27.38% |
2023 Q4 | 7.73 Million AUD | 0.0% |
2022 Q2 | 10.09 Million AUD | 0.0% |
2022 Q4 | 10.64 Million AUD | 0.0% |
2022 FY | 10.64 Million AUD | 17.67% |
2021 Q2 | 8.5 Million AUD | 0.0% |
2021 Q4 | 9.04 Million AUD | 0.0% |
2021 FY | 9.04 Million AUD | 31.01% |
2020 Q2 | 5.35 Million AUD | 0.0% |
2020 FY | 6.9 Million AUD | -25.81% |
2020 Q4 | 6.9 Million AUD | 0.0% |
2019 FY | 9.31 Million AUD | 109.73% |
2019 Q2 | 5.67 Million AUD | 0.0% |
2019 Q4 | 9.31 Million AUD | 0.0% |
2018 Q4 | 4.43 Million AUD | 0.0% |
2018 FY | 4.43 Million AUD | -45.13% |
2018 Q2 | 5.47 Million AUD | 0.0% |
2017 FY | 8.08 Million AUD | -24.6% |
2017 Q4 | 8.08 Million AUD | 0.0% |
2017 Q2 | 8.9 Million AUD | 0.0% |
2016 Q3 | 1.38 Million AUD | 0.0% |
2016 FY | 10.72 Million AUD | 1009.52% |
2016 Q1 | - AUD | 0.0% |
2016 Q4 | 1.38 Million AUD | 0.0% |
2015 FY | 967.07 Thousand AUD | 110.34% |
2014 FY | 459.76 Thousand AUD | -24.35% |
2013 FY | 607.75 Thousand AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Acrux Limited | 8.96 Million AUD | 37.822% |
Actinogen Medical Limited | 21.31 Million AUD | 73.85% |
AnteoTech Limited | 9.38 Million AUD | 40.594% |
Argenica Therapeutics Limited | 16.37 Million AUD | 65.972% |
Arovella Therapeutics Limited | 13.28 Million AUD | 58.049% |
Anatara Lifesciences Ltd | 1.67 Million AUD | -233.429% |
Alterity Therapeutics Limited | 19.22 Million AUD | 71.01% |
Amplia Therapeutics Limited | 14.84 Million AUD | 62.459% |
Avecho Biotechnology Limited | 7.31 Million AUD | 23.859% |
Bio-Gene Technology Limited | 3.15 Million AUD | -76.384% |
Biome Australia Limited | 8.27 Million AUD | 32.667% |
Biotron Limited | 493.47 Thousand AUD | -1029.336% |
Botanix Pharmaceuticals Limited | 112.46 Million AUD | 95.045% |
BTC Health Limited | 5.14 Million AUD | -8.239% |
Chimeric Therapeutics Limited | 15.27 Million AUD | 63.511% |
CSL Limited | 56.93 Billion AUD | 99.99% |
Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 96.396% |
Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 97.589% |
Cynata Therapeutics Limited | 8.38 Million AUD | 33.562% |
Dimerix Limited | 32.07 Million AUD | 82.627% |
EZZ Life Science Holdings Limited | 25.55 Million AUD | 78.19% |
Hexima Limited | 2.26 Million AUD | -145.614% |
Island Pharmaceuticals Limited | 2.56 Million AUD | -117.316% |
Immuron Limited | 15.54 Million AUD | 64.161% |
Immutep Limited | 147.44 Million AUD | 96.22% |
Imugene Limited | 151.39 Million AUD | 96.319% |
Invex Therapeutics Ltd | 6.12 Million AUD | 8.939% |
Memphasys Limited | 12.43 Million AUD | 55.165% |
Nanollose Limited | 241.95 Thousand AUD | -2203.359% |
Neuren Pharmaceuticals Limited | 247.97 Million AUD | 97.753% |
Noxopharm Limited | 6.78 Million AUD | 17.848% |
NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -2.523% |
Nyrada Inc. | 5.9 Million AUD | 5.658% |
Orthocell Limited | 26.61 Million AUD | 79.061% |
PharmAust Limited | 11.12 Million AUD | 49.905% |
Patrys Limited | 4.16 Million AUD | -33.916% |
Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 79.653% |
Proteomics International Laboratories Limited | 10.87 Million AUD | 48.755% |
Prescient Therapeutics Limited | 20.39 Million AUD | 72.672% |
PYC Therapeutics Limited | 91.23 Million AUD | 93.892% |
Race Oncology Limited | 20.22 Million AUD | 72.45% |
Radiopharm Theranostics Limited | 72.03 Million AUD | 92.264% |
Recce Pharmaceuticals Ltd | 6.36 Million AUD | 12.506% |
Starpharma Holdings Limited | 36.81 Million AUD | 84.862% |
Telix Pharmaceuticals Limited | 398.3 Million AUD | 98.601% |
Tissue Repair Ltd | 19.38 Million AUD | 71.258% |
Zelira Therapeutics Limited | 5.18 Million AUD | -7.516% |